Assessment of Lung Recruitablity of Acute Respiratory Distress Syndrome With SARS-CoV-2 Pneumonia by Electrical Impedance Tomography
1 other identifier
observational
43
1 country
1
Brief Summary
Novel coronavirus (SARS-CoV-2: severe acute respiratory coronavirus 2) pneumonia often develop the acute respiratory distress syndrome (ARDS). Lung protective ventilation strategy consisting of low tidal volume and high positive end-expiratory pressure (PEEP) is recommended. However, it is not clear whether injured lungs from SARS-CoV-2 pneumonia have the same mechanical properties, especially response to PEEP as common ARDS. Therefore, the investigators propose an observational study to analyze respiratory mechanics and lung recruitablity using EIT (electrical impedance tomography) in patients with ARDS due to SARS-CoV-2 pneumonia.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started May 2020
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
May 11, 2020
CompletedFirst Submitted
Initial submission to the registry
July 14, 2020
CompletedFirst Posted
Study publicly available on registry
July 16, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
February 28, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
February 28, 2021
CompletedJuly 1, 2021
July 1, 2020
10 months
July 14, 2020
June 30, 2021
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
The distribution of ventilation
The distribution of ventilation measured by EIT at PEEP 5 and 15.
Through study completion (up to 24 hours)
Secondary Outcomes (4)
Silent spaces
Through study completion (up to 24 hours)
Respiratory system compliance
Through study completion (up to 24 hours)
Oxygenation
Through study completion (up to 24 hours)
Dead space ventilation ratio
Through study completion (up to 24 hours)
Eligibility Criteria
Adult patients with ARDS due to SARS-CoV-2 pneumonia under mechanical ventilation in intensive care unit.
You may qualify if:
- Patients with positive SARS-CoV-2 infection*
- Patients with ARDS under mechanical ventilation**
- Patients ≧ 18 years old
- Definition of SARS-CoV-2 infection positive: SARS-CoV-2 infection is defined as being positive in RT-PCR (real time reverse transcriptase-polymerase chain reaction) assay using nasal or pharyngeal swab samples.
- Definition of ARDS is as per the Berlin definition (PaO2/FiO2 ≦ 300 mmHg with PEEP ≧ 5 cmH2O)
You may not qualify if:
- Contraindication for EIT monitoring
- Unstable spine or pelvic fractures
- Pacemaker, automatic implantable cardioverter defibrillator
- Skin lesions between the 4th and 5th ribs where the EIT belt is worn
- Pregnancy
- DNR (do-not-resuscitate)
- Increased intracranial pressure (\> 18 mmHg)
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Osaka Universitylead
- Hospital Rebagliaticollaborator
Study Sites (1)
Osaka University Hospital
Suita, Osaka, 565-0871, Japan
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Takeshi Yoshida, M.D., Ph.D.
Osaka University
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
July 14, 2020
First Posted
July 16, 2020
Study Start
May 11, 2020
Primary Completion
February 28, 2021
Study Completion
February 28, 2021
Last Updated
July 1, 2021
Record last verified: 2020-07
Data Sharing
- IPD Sharing
- Will not share